EyePoint, Inc.
NASDAQ: EYPT. Canonical company identity and public leadership record.
US
- Alpha ID
- alpha:company:90bac025-081c-4c53-a0c6-a2476e8cb44b
- SEC CIK
- 0001314102
- Record version
- vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce, published Oct 16, 2026
- Newest evidence
- Apr 27, 2026
- Monitoring
- Not yet monitored Details
- Integrity
- Not yet signed Methodology
- CEO
- Jay Duker, M.D.Since Apr 27, 2026
- Chair
- Göran Ando
- Independent
- Not published7 directors published
- Published claims
- 182 distinct sources
- Evidence records
- 50 pinned
- Source conflicts
- 0None open
Built from 2 distinct sources and 5 evidence records. Every Claim links to where it appears. Where nothing was published, the record states the coverage gap.
Public record. Alpha publishes governance facts about this organization from regulatory filings and company statements. Private enterprise overlay data is never projected here. The company can claim the record, correct, or dispute any Claim. How this works
DIRECTOR APPOINTED
ABSTAIN Computershare Position seat on EyePoint, Inc., effective 2026-04-27.
Monitoring
ContinuousWhat the published record states about identity, evidence, evaluation, monitoring, authority, and freshness. Watched-source schedules are not published for this record.
- IdentityunclaimedPublished
- Evidencesource_reportedPublished
- Evaluationnot_evaluatedPublished
- MonitoringNot yet published for this record.Not published
- AuthorityNot yet published for this record.Not published
- FreshnesscurrentPublished
Leadership
Evidence| Role | Person | Since | Status | Claim |
|---|---|---|---|---|
| President, Chief Executive Officer and Director | Jay Duker, M.D. | Apr 2026 | current | Source reportedE4 |
| Chief Medical Officer | Ramiro Ribeiro, M.D. | Apr 2026 | current | Source reportedE5 |
| Executive Vice President and Chief Financial Officer | George Elston | Not captured | unknown | Source reportedE2 |
| President and Chief Executive Officer | Jay S. Duker | Not captured | unknown | Source reportedE2 |
| Chief Medical Officer | Ramiro Ribeiro | Not captured | unknown | Source reportedE2 |
Board of directors
Evidence7 directors published. Independence determinations are not published for every director.
| Director | Status | Since | Committees | Claim |
|---|---|---|---|---|
| ABSTAIN Computershare Position | Independence not published | 2026 | None published | Source reportedE3 |
| Fred Hassan | Independence not published | 2024 | None published | Source reportedE3 |
| John B. Landis | Independence not published | 2018 | None published | Source reportedE3 |
| Karen Zaderej | Independence not published | 2022 | None published | Source reportedE3 |
| Reginald J. Sanders | Independence not published | 2025 | None published | Source reportedE3 |
| Stuart Duty | Independence not published | 2023 | None published | Source reportedE3 |
| Wendy DiCicco | Independence not published | 2019 | None published | Source reportedE3 |
| Göran Ando | IndependentChair | Not published | None published | Source reportedE2 |
| Jay S. Duker | Not independent | Not published | Chief Executive Officer and Director | Source reportedE2 |
Committees and risk ownership
Evidence| Committee | Chair | Members | Risks assigned |
|---|---|---|---|
| Chief Executive Officer and Director | Not published | Jay S. Duker | Not described in the published record |
Control and voting power
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Authority to act
Evidence and agent registryWho can act for the company, and on whose authority. This is what a counterparty's agent checks before it accepts an order, signs, or pays.
Financials and market context
EvidenceGovernance and policies
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Risk, audit, and cyber
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
AI oversight and accountability
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Legal and regulatory
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Compensation
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Other published claims
EvidencePublished Claims that belong to no section above. Each keeps its permalink, evidence, and assertion state.
Not yet in this record
CoverageA gap is a coverage state, not a negative finding. These sections are expected for this entity class and are not yet published.
- Corporate structureNot reviewed. Parent, subsidiary and predecessor structure explains who is governed.
- OwnershipNot reviewed. Ownership and voting power determine who can influence the board.
- FinancialsNot reviewed. Governance-relevant financial context frames capital and audit decisions.
- CompensationNot reviewed. Pay design shows how incentives are governed.
- GovernanceNot reviewed. Governing documents and provisions set the rules of the enterprise.
- Shareholder governanceNot reviewed. Meeting and vote records show shareholder dissent and support.
- AuditNot reviewed. Auditor, controls and restatements show assurance over reporting.
- LegalNot reviewed. Material legal and regulatory matters show enforcement exposure.
- RiskNot reviewed. Risk ownership links the board, committees, executives and controls.
- CyberNot reviewed. Cyber and data governance is a disclosed oversight domain.
- AI governanceNot reviewed. AI oversight is a differentiated Alpha governance domain.
- Markets externalNot reviewed. Auditors, advisors, investors and regulators form the external ecosystem.
- Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.
- Only explicitly published canonical company identity and current confirmed public roles are included.Only explicitly published canonical company identity and current confirmed public roles are included.
- Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.
- Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.
- This Company Profile is an identity and evidence record, not an Alpha rating.This Company Profile is an identity and evidence record, not an Alpha rating.
Linked people
Same claims as person records- Jay Duker, M.D.President, Chief Executive Officer and Directorcompany:90bac025-081c-4c53-a0c6-a2476e8cb44b:leadership_role:15
- Ramiro Ribeiro, M.D.Chief Medical Officercompany:90bac025-081c-4c53-a0c6-a2476e8cb44b:leadership_role:18
- George ElstonExecutive Vice President and Chief Financial Officercompany:90bac025-081c-4c53-a0c6-a2476e8cb44b:leadership_role:14
- Jay S. DukerPresident and Chief Executive Officer; President, Chief Executive Officer and Directorcompany:90bac025-081c-4c53-a0c6-a2476e8cb44b:leadership_role:16, company:90bac025-081c-4c53-a0c6-a2476e8cb44b:leadership_role:8
- Ramiro RibeiroChief Medical Officercompany:90bac025-081c-4c53-a0c6-a2476e8cb44b:leadership_role:17
- ABSTAIN Computershare PositionDirectorcompany:90bac025-081c-4c53-a0c6-a2476e8cb44b:leadership_role:6
- Fred HassanDirectorcompany:90bac025-081c-4c53-a0c6-a2476e8cb44b:leadership_role:7
- John B. LandisDirectorcompany:90bac025-081c-4c53-a0c6-a2476e8cb44b:leadership_role:9
- Karen ZaderejDirectorcompany:90bac025-081c-4c53-a0c6-a2476e8cb44b:leadership_role:10
- Reginald J. SandersDirectorcompany:90bac025-081c-4c53-a0c6-a2476e8cb44b:leadership_role:11
- Stuart DutyDirectorcompany:90bac025-081c-4c53-a0c6-a2476e8cb44b:leadership_role:12
- Wendy DiCiccoDirectorcompany:90bac025-081c-4c53-a0c6-a2476e8cb44b:leadership_role:13
- Göran AndoChair of the Board of Directorscompany:90bac025-081c-4c53-a0c6-a2476e8cb44b:leadership_role:5
Subject and corrections
Public-role doctrineThis record exists because the company is in the published Registry. The company can claim the record, correct, or dispute any Claim. Corrections are versioned and the original stays in history.
- Basis
- Published company record built from public sources
- Sources
- 5 evidence records cited. 0 with redistribution rights.
- Never published
- Private enterprise overlay data: deployments, authority grants, TrustChecks, receipts, telemetry
- Record claimed
- No
- Open disputes
- 0
- Identity ownership
- unclaimed
If the company claims the record, its statements appear as their own assertion state and never overwrite the cited evidence.
Evidence
Authority and rights- E1Alpha canonical company public projection. canonical identity. Retrieved Oct 16, 2026. Cited by 4 Claims.
- E2sec def 14a. Published Apr 27, 2026. Retrieved Sep 6, 2026. Cited by 5 Claims.
- E3sec proxy. Published Apr 27, 2026. Retrieved Sep 2, 2026. Cited by 7 Claims.
- E4sec filing. Published Apr 27, 2026. Retrieved May 4, 2026. Cited by 1 Claim.
- E5sec filing. Published Apr 27, 2026. Retrieved May 4, 2026. Cited by 1 Claim.
What changed in version public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce
vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce published Oct 16, 2026- ABSTAIN Computershare Position seat on EyePoint, Inc., effective 2026-04-27.
- Jay Duker, M.D. executive of EyePoint, Inc., effective 2026-04-27.
- Ramiro Ribeiro, M.D. executive of EyePoint, Inc., effective 2026-04-27.
- Reginald J. Sanders seat on EyePoint, Inc., effective 2025-01-01.
- Fred Hassan seat on EyePoint, Inc., effective 2024-01-01.
- Stuart Duty seat on EyePoint, Inc., effective 2023-01-01.
- Karen Zaderej seat on EyePoint, Inc., effective 2022-01-01.
- Wendy DiCicco seat on EyePoint, Inc., effective 2019-01-01.
- John B. Landis seat on EyePoint, Inc., effective 2018-01-01.



